# The Safety and Efficacy of XytriX (Umbilical Cord-Derived Mesenchymal Stem Cells) in the Treatment of Knee Osteoarthritis

> **NCT07487766** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **TricelX Inc.** · enrollment: 75 (estimated)

## Conditions studied

- Osteoarthritis

## Interventions

- **BIOLOGICAL:** Mesenchymal Stem Cell Injection

## Key facts

- **NCT ID:** NCT07487766
- **Lead sponsor:** TricelX Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2027-05
- **Final completion:** 2028-12
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07487766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07487766, "The Safety and Efficacy of XytriX (Umbilical Cord-Derived Mesenchymal Stem Cells) in the Treatment of Knee Osteoarthritis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07487766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*